4//SEC Filing
IMMUNE PHARMACEUTICALS INC 4
Accession 0001144204-15-067600
CIK 0001208261operating
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:05 PM ET
Size
5.7 KB
Accession
0001144204-15-067600
Insider Transaction Report
Form 4
Luchi Monica E.
EVP & CMO
Transactions
- Award
Stock Option
2015-11-19+400,000→ 400,000 totalExercise: $0.98Exp: 2025-11-19→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]The stock options shall vest over a period of three years, with 1/3 of the options vesting on the first anniversary of the date of grant and the remainder vesting quarterly over the following two-year period.
- [F2]The stock options were granted as an inducement grant pursuant to NASDAQ Listing Rule 5635(c)(4) in connection with the reporting person's appointment as EVP, Global Drug Development and Chief Medical Officer.
Documents
Issuer
IMMUNE PHARMACEUTICALS INC
CIK 0001208261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001208261
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 6:05 PM ET
- Size
- 5.7 KB